ABBVIE SPAIN, S.L.U., Incyte Biosciences Iberica S.L., AMGEN, S.A., ASTRAZENECA FARMACEUTICA SPAIN, S.A., MERZ THERAPEUTICS IBERIA, S.L., BIOGEN SPAIN, S.L.U., BRISTOL MYERS SQUIBB, S.A., DAIICHI SANKYO ESPAÑA,S.A., ALFASIGMA ESPAÑA, SL, GILEAD SCIENCES, S.L., GLAXOSMITHKLINE, S.A., JANSSEN-CILAG, S.A., LILLY, S.A, Organon Salud S.L., LUNDBECK ESPAÑA, S.A., MERCK S.L.U., MERCK SHARP & DOHME DE ESPAÑA, S.A., NOVARTIS FARMACEUTICA, S.A., OTSUKA PHARMACEUTICAL, S.A., PFIZER, S.L.U., ROCHE FARMA, S.A., SANOFI AVENTIS, S.A., TAKEDA FARMACEUTICA ESPAÑA SA, TEVA PHARMA, S.L.U., UCB PHARMA, S.A., VERTEX PHARMACEUTICALS SPAIN S.L., LABORATORIOS VIIV HEALTHCARE, S.L.

Government contractor and tender participant